Hemostemix Company
Hemostemix is a public clinical-stage biotechnology company.
Technology:
Stem cell therapy
Industry:
Cell Therapy, Public
Headquarters:
Blackfalds, Alberta, Canada
Founded Date:
2006-01-01
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
2
Total Funding:
11513827
Estimated Revenue:
$1M to $10M
Last Funding Date:
2023-01-19
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership